AI-generated summary
This review examines whether photobiomodulation might act through the Wnt/β-catenin pathway in apexogenesis, a pulp therapy for immature teeth. The authors report that in vitro evidence on dental pulp stem cells and apical papilla stem cells is heterogeneous and limited, with odontogenic differentiation the most consistent finding. No study has directly tested PBMT effects on Wnt/β-catenin signaling, so therapeutic benefit is described as unproven.
- Who or what was studied
- Dental pulp stem cells (DPSCs) and stem cells from the apical papilla (SCAPs) studied in vitro, in the context of immature teeth undergoing apexogenesis
- Limits stated in the abstract
- The abstract states the evidence is heterogeneous and limited, relies mainly on the MTT metabolic assay, identifies no superior wavelength or fluence, and includes no direct mechanistic or animal studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.